HealthcareServices

Global Lupus Nephritis Market Report 2026–2035: Key Forecasts and Growth Areas

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the lupus nephritis market from 2026–2035 with trusted insights from The Business Research Company

How much is the Lupus Nephritis Market valued at in 2026, and what valuation is forecast for 2030?

The market size for lupus nephritis has shown robust growth over recent years. It is anticipated to increase from $2.08 billion in 2025 to $2.24 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.7%. This historical expansion can be attributed to the rising prevalence of systemic lupus erythematosus, improvements in kidney biopsy and diagnostic practices, the extensive application of corticosteroids in treatment, the growth of hospital-based nephrology care, and increased awareness of autoimmune kidney diseases.

The lupus nephritis market is projected to experience substantial expansion in the coming years. It is anticipated to reach $2.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This forecasted growth is attributable to factors such as increased investment in the development of biologic drugs, a greater emphasis on early intervention to avert kidney failure, wider uptake of combination therapy regimens, the expansion of specialized nephrology clinics, and increased healthcare expenditure dedicated to managing autoimmune diseases. Key trends during this period are expected to involve a heightened focus on prompt diagnosis and disease surveillance, the increasing use of immunosuppressive and biologic treatments, a stronger push towards individualized treatment strategies, the broadening of long-term disease management plans, and heightened awareness regarding kidney complications linked to autoimmune conditions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp

What Drivers Are Influencing The Growth Of The Lupus Nephritis Market?

The rising occurrence of genetic predisposition is anticipated to propel the growth of the lupus nephritis market moving forward. Genetic predisposition describes an individual’s inherited genetic traits that elevate their likelihood of developing particular diseases or conditions. The expanding prevalence of genetic predisposition stems from factors such as heredity, environmental influences, and alterations in specific genes. This increasing prevalence plays a crucial role in the development of lupus nephritis, highlighting the impact of inherited genetic factors in autoimmune diseases, especially those affecting kidney function. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based national charity, the UK CF Registry recorded 11,148 registered patients in 2022, which increased to 11,318 in 2024, reflecting a 1.52% increase in individuals with cystic fibrosis (CF). Consequently, the growing prevalence of genetic predisposition is driving the expansion of the lupus nephritis market.

What Segments Are Included Within The Lupus Nephritis Market?

The lupus nephritis market covered in this report is segmented –

1) By Stage: Class 1, Class 2, Class 3, Other Stages

2) By Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis

2) By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition

3) By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation

4) By Other Stages: Class 4 (Diffuse Lupus Nephritis), Class 5 (Membranous Lupus Nephritis), Class 6 (Advanced Sclerotic Lupus Nephritis)

Which Trends Are Expected To Influence The Lupus Nephritis Market In The Upcoming Years?

Key companies operating within the lupus nephritis market are dedicating efforts to developing advanced second-generation calcineurin inhibitors with the goal of enhancing treatment efficacy and improving long-term kidney outcomes for patients. These second-generation calcineurin inhibitors are utilized in lupus nephritis to diminish inflammation and prevent kidney damage by modulating immune responses. For instance, in September 2024, Aurinia Pharmaceuticals Inc., a Canada-based commercial-stage biopharmaceutical company, announced that the Japanese Ministry of Health, Labour, and Welfare granted approval for LUPKYNIS (voclosporin) for the treatment of lupus nephritis. This approval permits voclosporin to be administered in combination with mycophenolate mofetil (MMF), based on data from the AURORA Clinical Program, which demonstrated its safety and efficacy. The approval signifies a major achievement in expanding treatment alternatives for lupus nephritis patients in Japan, contributing to improved disease management and outcomes.

Who Are The Primary Competitors In The Global Lupus Nephritis Market?

Major companies operating in the lupus nephritis market are F Hoffmann La Roche Ltd, Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, AstraZeneca PLC, Pfizer Inc, Johnson and Johnson, Merck and Co Inc, Sanofi, AbbVie Inc, Bayer AG, Amgen Inc, UCB SA, Otsuka Pharmaceutical Co Ltd, Aurinia Pharmaceuticals Inc, RemeGen Co Ltd, Kezar Life Sciences, Equillium Inc, Kyverna Therapeutics Inc, Biogen Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report

Which Regions Are Poised For Strategic Growth In The Lupus Nephritis Market?

Asia-Pacific was the largest region in the lupus nephritis market in 2025. The regions covered in the lupus nephritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lupus Nephritis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22044&type=smp

Browse Through More Reports Similar to the Global Lupus Nephritis Market 2026, By The Business Research Company

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Cutaneous Lupus Erythematosus Market Report 2026

https://www.thebusinessresearchcompany.com/report/cutaneous-lupus-erythematosus-global-market-report

Lupus Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lupus-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795